Laurus Labs Limited
LAURUSLABS
Rangering i aksjer
#1745
Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited,... Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited, along with its subsidiaries, operates as a diversified global pharmaceutical company. It focuses on the research, manufacturing, and international distribution of a broad spectrum of medicines and active pharmaceutical ingredients (APIs). The company's API and advanced intermediate offerings cover key therapeutic domains such as anti-retroviral (ARV), antidiabetic, cardiovascular, proton pump inhibitors (PPIs), oncology, gastroenterology, and hepatitis C. Additionally, Laurus Labs develops and produces oral solid dosage forms targeting ARV, antidiabetic, cardiovascular, PPI, and central nervous system (CNS) conditions. Beyond its proprietary products, the firm extends its expertise through contract development and manufacturing services for other pharmaceutical enterprises. It also supplies specialized ingredients vital for nutraceutical, dietary supplement, and cosmeceutical applications. Furthermore, Laurus Labs is at the forefront of innovation, engineering novel enzymatic solutions for industrial biotechnology, and providing animal-origin-free recombinant proteins and enzymes for biopharmaceutical use, alongside offering a range of business support services within the pharmaceutical industry.
Aksjekurs
$22.83
Sist synkronisert: 2026-10-19
Markedsverdi
$12.34B
Endring (1 dag)
0.51%
Endring (1 år)
117.95%
Land
IN
Handel Laurus Labs Limited (LAURUSLABS)
Kategori
Healthcare
Antall utestående aksjer for Laurus Labs Limited (LAURUSLABS)
Antall utestående aksjer per June 2026: 539.79M
Ifølge Laurus Labs Limited sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 539.79M. Ved slutten av March 2024 hadde selskapet 540.57M utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Laurus Labs Limited (LAURUSLABS) fra 2013 til 2026
Utestående aksjer ved utgangen av hvert år
| År | Utestående aksjer | Endre |
|---|---|---|
| 2026 (TTM) | 539.79M | 0.03% |
| 2025 | 539.64M | -0.17% |
| 2024 | 540.57M | 0.16% |
| 2023 | 539.69M | 0.11% |
| 2022 | 539.10M | 0.19% |
| 2021 | 538.06M | 0.87% |
| 2020 | 533.42M | 0.13% |
| 2019 | 532.75M | 0.19% |
| 2018 | 531.76M | 16.15% |
| 2017 | 457.83M | -6.95% |
| 2016 | 492.04M | 10.95% |
| 2015 | 443.48M | 0.00% |
| 2014 | 443.48M | 9.11% |
| 2013 | 406.44M | 0.00% |
Utestående aksjer for lignende selskaper eller konkurrenter
| Selskap | Utestående aksjer | Forskjell | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | 344.49% |
IN
|
